Takashita, E., Yamayoshi, S., Simon, V., van Bakel, H., Sordillo, E. M., Pekosz, A., . . . Kawaoka, Y. (2022). Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants. The New England journal of medicine, 387(5), 468-470. https://doi.org/10.1056/NEJMc2207519
Chicago Style (17th ed.) CitationTakashita, Emi, et al. "Efficacy of Antibodies and Antiviral Drugs Against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants." The New England Journal of Medicine 387, no. 5 (2022): 468-470. https://doi.org/10.1056/NEJMc2207519.
MLA (9th ed.) CitationTakashita, Emi, et al. "Efficacy of Antibodies and Antiviral Drugs Against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants." The New England Journal of Medicine, vol. 387, no. 5, 2022, pp. 468-470, https://doi.org/10.1056/NEJMc2207519.